stopwords, and 2-character and smaller words are excluded
TICAM-1, an adaptor molecule that participates in Toll-like
receptor 3-mediated interferon-beta induction
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T
NATURE IMMUNOLOGY 4 (2): 161-167 FEB 2003
and the citing papers
Total: 668, Nodes: 194, Word count: 1792, All words count: 2511
View: Overview. Sorted by LCS.
Page 3 of 4: [ 1 2 3 4 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 401 | APPROACH | 1 | 0.5 | 0 | 9
|
| 402 | APPROACHES | 1 | 0.5 | 0 | 0
|
| 403 | ARTHRITOGENIC | 1 | 0.5 | 0 | 1
|
| 404 | ASSAY | 1 | 0.5 | 0 | 10
|
| 405 | ASSESSMENT | 1 | 0.5 | 0 | 10
|
| 406 | ASSOCIATED | 1 | 0.5 | 0 | 0
|
| 407 | ASSOCIATION | 1 | 0.5 | 0 | 8
|
| 408 | ATTRACTION | 1 | 0.5 | 0 | 0
|
| 409 | AUTOIMMUNE | 1 | 0.5 | 0 | 0
|
| 410 | AUTOPHOSPHORYLATION | 1 | 0.5 | 0 | 6
|
| 411 | AUTOREGULATORY | 1 | 0.5 | 0 | 0
|
| 412 | AVAILABILITY | 1 | 0.5 | 0 | 6
|
| 413 | B-ACTIVATING | 1 | 0.5 | 0 | 1
|
| 414 | BACTERIA-INFECTED | 1 | 0.5 | 0 | 5
|
| 415 | BASED | 1 | 0.5 | 0 | 2
|
| 416 | BETA-STAT | 1 | 0.5 | 0 | 4
|
| 417 | BIOINFORMATICS | 1 | 0.5 | 0 | 0
|
| 418 | BIOLOGY | 1 | 0.5 | 0 | 3
|
| 419 | BRUTON | 1 | 0.5 | 0 | 4
|
| 420 | BTK | 1 | 0.5 | 0 | 4
|
| 421 | CARDIAC | 1 | 0.5 | 0 | 4
|
| 422 | CATIONIC | 1 | 0.5 | 0 | 0
|
| 423 | CD11C | 1 | 0.5 | 0 | 3
|
| 424 | CELL-DERIVED | 1 | 0.5 | 0 | 3
|
| 425 | CELL-WALL | 1 | 0.5 | 0 | 1
|
| 426 | CELLULAR | 1 | 0.5 | 0 | 0
|
| 427 | CHARACTERIZATION | 2 | 1.0 | 0 | 4
|
| 428 | CHEMOKINE | 1 | 0.5 | 0 | 0
|
| 429 | CHIMERIC | 1 | 0.5 | 0 | 9
|
| 430 | CHLAMYDIA | 2 | 1.0 | 0 | 1
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 431 | CHRONIC | 1 | 0.5 | 0 | 2
|
| 432 | CLOSER | 1 | 0.5 | 0 | 0
|
| 433 | CONFERS | 1 | 0.5 | 0 | 0
|
| 434 | CONTAINING | 1 | 0.5 | 0 | 0
|
| 435 | CONTRIBUTES | 1 | 0.5 | 0 | 1
|
| 436 | CONTROLLING | 1 | 0.5 | 0 | 13
|
| 437 | CORNEAL | 1 | 0.5 | 0 | 0
|
| 438 | COUNTERACT | 1 | 0.5 | 0 | 0
|
| 439 | CRITICALLY | 3 | 1.5 | 0 | 11
|
| 440 | CRUZI | 1 | 0.5 | 0 | 12
|
| 441 | CULTURE | 1 | 0.5 | 0 | 0
|
| 442 | CWS | 1 | 0.5 | 0 | 1
|
| 443 | CYCLOOXYGENASE | 1 | 0.5 | 0 | 7
|
| 444 | CYTOTOXICITY | 1 | 0.5 | 0 | 2
|
| 445 | DANGER | 1 | 0.5 | 0 | 4
|
| 446 | DANIO | 1 | 0.5 | 0 | 0
|
| 447 | DC-VIRUS | 1 | 0.5 | 0 | 3
|
| 448 | DEACTIVATION | 1 | 0.5 | 0 | 10
|
| 449 | DEATH | 1 | 0.5 | 0 | 4
|
| 450 | DEFENCE | 1 | 0.5 | 0 | 0
|
| 451 | DEFENSE | 1 | 0.5 | 0 | 0
|
| 452 | DEFINED | 1 | 0.5 | 0 | 10
|
| 453 | DELTA | 1 | 0.5 | 0 | 3
|
| 454 | DERIVATIVES | 1 | 0.5 | 0 | 0
|
| 455 | DETERMINANTS | 1 | 0.5 | 0 | 0
|
| 456 | DIMINISHED | 1 | 0.5 | 0 | 3
|
| 457 | DIPEPTIDE | 1 | 0.5 | 0 | 0
|
| 458 | DISEASE | 2 | 1.0 | 0 | 11
|
| 459 | DISORDERS | 1 | 0.5 | 0 | 1
|
| 460 | DISTINCTIVE | 1 | 0.5 | 0 | 9
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 461 | DNA | 1 | 0.5 | 0 | 7
|
| 462 | EDGED | 1 | 0.5 | 0 | 3
|
| 463 | EFFECTS | 1 | 0.5 | 0 | 1
|
| 464 | ELICITS | 1 | 0.5 | 0 | 1
|
| 465 | EMERGING | 1 | 0.5 | 0 | 2
|
| 466 | ENCODED | 1 | 0.5 | 0 | 1
|
| 467 | ENDOTHELIAL | 1 | 0.5 | 0 | 4
|
| 468 | ENDOTOXINS | 1 | 0.5 | 0 | 0
|
| 469 | EPITHELIAL | 3 | 1.5 | 0 | 4
|
| 470 | EVOLUTION | 1 | 0.5 | 0 | 0
|
| 471 | EXOGENOUS | 1 | 0.5 | 0 | 6
|
| 472 | EXPERIMENTAL | 2 | 1.0 | 0 | 0
|
| 473 | EXPRESS | 1 | 0.5 | 0 | 0
|
| 474 | EXTRINSIC | 1 | 0.5 | 0 | 4
|
| 475 | FEMALE | 1 | 0.5 | 0 | 3
|
| 476 | FIVE | 1 | 0.5 | 0 | 2
|
| 477 | FORMATION | 1 | 0.5 | 0 | 8
|
| 478 | FULL-LENGTH | 1 | 0.5 | 0 | 0
|
| 479 | FULLY | 1 | 0.5 | 0 | 3
|
| 480 | FUNCTIONAL | 3 | 1.5 | 0 | 12
|
| 481 | FUNCTIONS | 3 | 1.5 | 0 | 6
|
| 482 | GAMMA | 1 | 0.5 | 0 | 3
|
| 483 | GENE-INDUCING | 1 | 0.5 | 0 | 1
|
| 484 | GENERATED | 1 | 0.5 | 0 | 0
|
| 485 | GLUCOCORTICOIDS | 1 | 0.5 | 0 | 1
|
| 486 | GROWS | 1 | 0.5 | 0 | 2
|
| 487 | HASHIMOTO | 1 | 0.5 | 0 | 0
|
| 488 | HAT | 1 | 0.5 | 0 | 2
|
| 489 | HCVNS | 1 | 0.5 | 0 | 0
|
| 490 | HEAT | 1 | 0.5 | 0 | 1
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 491 | HEPATOCYTES | 1 | 0.5 | 0 | 0
|
| 492 | HETEROGENEITY | 1 | 0.5 | 0 | 1
|
| 493 | HOMOLOGY | 1 | 0.5 | 0 | 1
|
| 494 | HOMOTYPIC | 1 | 0.5 | 0 | 0
|
| 495 | I-C | 1 | 0.5 | 0 | 0
|
| 496 | IFN | 3 | 1.5 | 0 | 1
|
| 497 | IFN-GAMMA | 1 | 0.5 | 0 | 4
|
| 498 | IKK-EPSILON | 1 | 0.5 | 0 | 1
|
| 499 | IL-12P | 1 | 0.5 | 0 | 1
|
| 500 | IMMUNE-MEDIATED | 1 | 0.5 | 0 | 1
|
| 501 | IMMUNOLOGY | 1 | 0.5 | 0 | 7
|
| 502 | IMMUNOMODULATION | 1 | 0.5 | 0 | 2
|
| 503 | IMMUNOSUPPRESSIVE | 1 | 0.5 | 0 | 1
|
| 504 | IMPROVE | 1 | 0.5 | 0 | 0
|
| 505 | INFECTION-INDUCED | 1 | 0.5 | 0 | 4
|
| 506 | INFLAMMATION | 2 | 1.0 | 0 | 1
|
| 507 | INHIBITION | 2 | 1.0 | 0 | 0
|
| 508 | INSECTS | 1 | 0.5 | 0 | 3
|
| 509 | INTEGRATION | 1 | 0.5 | 0 | 0
|
| 510 | INTERACTING | 1 | 0.5 | 0 | 0
|
| 511 | INTERACTS | 1 | 0.5 | 0 | 2
|
| 512 | INTERLEUKIN-18-MEDIATED | 1 | 0.5 | 0 | 4
|
| 513 | INTERPLAY | 1 | 0.5 | 0 | 3
|
| 514 | INTRACELLULAR | 1 | 0.5 | 0 | 4
|
| 515 | INTRINSIC | 1 | 0.5 | 0 | 4
|
| 516 | INVERTEBRATE | 1 | 0.5 | 0 | 0
|
| 517 | ISOFORM | 1 | 0.5 | 0 | 0
|
| 518 | ISRE | 1 | 0.5 | 0 | 0
|
| 519 | KIDNEY | 1 | 0.5 | 0 | 4
|
| 520 | KINASE-ASSOCIATED | 1 | 0.5 | 0 | 1
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 521 | LACKING | 1 | 0.5 | 0 | 12
|
| 522 | LEADING | 1 | 0.5 | 0 | 0
|
| 523 | LEADS | 1 | 0.5 | 0 | 0
|
| 524 | LEARNED | 1 | 0.5 | 0 | 0
|
| 525 | LESSONS | 3 | 1.5 | 0 | 8
|
| 526 | LEVELS | 1 | 0.5 | 0 | 10
|
| 527 | LIGAND-REGULATED | 1 | 0.5 | 0 | 9
|
| 528 | LINKS | 1 | 0.5 | 0 | 1
|
| 529 | LIPOPOLYSACCHARIDE-BINDING | 1 | 0.5 | 0 | 2
|
| 530 | LIPOPOLYSACCHARIDE-INDUCIBLE | 1 | 0.5 | 0 | 0
|
| 531 | LIPOSOME | 1 | 0.5 | 0 | 0
|
| 532 | LISTERIA | 1 | 0.5 | 0 | 4
|
| 533 | LOOPS | 1 | 0.5 | 0 | 0
|
| 534 | LPS-INDUCED | 1 | 0.5 | 0 | 18
|
| 535 | MAL | 1 | 0.5 | 0 | 2
|
| 536 | MAMMALS | 1 | 0.5 | 0 | 3
|
| 537 | MAPK | 1 | 0.5 | 0 | 2
|
| 538 | MARINE | 1 | 0.5 | 0 | 0
|
| 539 | MAST | 1 | 0.5 | 0 | 10
|
| 540 | MDP | 1 | 0.5 | 0 | 0
|
| 541 | MECHNIKOV | 1 | 0.5 | 0 | 2
|
| 542 | MEDIATING | 1 | 0.5 | 0 | 1
|
| 543 | MEDIATORS | 1 | 0.5 | 0 | 0
|
| 544 | MEMBERS | 1 | 0.5 | 0 | 2
|
| 545 | MEMBRANE | 1 | 0.5 | 0 | 2
|
| 546 | MHC | 1 | 0.5 | 0 | 3
|
| 547 | MIKISS | 1 | 0.5 | 0 | 2
|
| 548 | MISMATCHED | 1 | 0.5 | 0 | 3
|
| 549 | MODEL | 1 | 0.5 | 0 | 0
|
| 550 | MODELS | 1 | 0.5 | 0 | 0
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 551 | MODULATE | 1 | 0.5 | 0 | 0
|
| 552 | MOLECULAR | 2 | 1.0 | 0 | 10
|
| 553 | MOLECULE-1-MEDIATED | 1 | 0.5 | 0 | 1
|
| 554 | MONOACYLATED | 1 | 0.5 | 0 | 0
|
| 555 | MONOCYTES | 1 | 0.5 | 0 | 2
|
| 556 | MONOCYTOGENES | 1 | 0.5 | 0 | 4
|
| 557 | MOTIF | 1 | 0.5 | 0 | 0
|
| 558 | MUCIN | 1 | 0.5 | 0 | 1
|
| 559 | MUCOSAL | 1 | 0.5 | 0 | 0
|
| 560 | MULTIPLE | 1 | 0.5 | 0 | 1
|
| 561 | MULTIPLEX | 1 | 0.5 | 0 | 10
|
| 562 | MURAMYL | 1 | 0.5 | 0 | 0
|
| 563 | MURINE | 1 | 0.5 | 0 | 5
|
| 564 | MYCOBACTERIA | 1 | 0.5 | 0 | 3
|
| 565 | NEGATIVE | 2 | 1.0 | 0 | 1
|
| 566 | NEGATIVE-STRAND | 1 | 0.5 | 0 | 4
|
| 567 | NEUTROPHILS | 1 | 0.5 | 0 | 0
|
| 568 | NEW | 2 | 1.0 | 0 | 1
|
| 569 | NIPAH | 1 | 0.5 | 0 | 0
|
| 570 | NONSECRETABLE | 1 | 0.5 | 0 | 0
|
| 571 | NUCLEAR | 1 | 0.5 | 0 | 0
|
| 572 | NUCLEOSOME | 1 | 0.5 | 0 | 1
|
| 573 | OLIGODEOXYNUCLEOTIDE | 1 | 0.5 | 0 | 8
|
| 574 | ONCHORHYNCHUS | 1 | 0.5 | 0 | 2
|
| 575 | ORTHOLOGS | 1 | 0.5 | 0 | 2
|
| 576 | OVEREXPRESSION | 1 | 0.5 | 0 | 0
|
| 577 | PAK | 1 | 0.5 | 0 | 1
|
| 578 | PARADIGMS | 1 | 0.5 | 0 | 0
|
| 579 | PARTICIPATE | 1 | 0.5 | 0 | 0
|
| 580 | PATHOGEN | 1 | 0.5 | 0 | 0
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 581 | PATHOGENS | 1 | 0.5 | 0 | 5
|
| 582 | PHENYLMETHIMAZOLE | 1 | 0.5 | 0 | 0
|
| 583 | PHYLOGENETICS | 1 | 0.5 | 0 | 0
|
| 584 | PIASY | 1 | 0.5 | 0 | 0
|
| 585 | PNEUMONIA | 1 | 0.5 | 0 | 2
|
| 586 | PNEUMONIAE | 2 | 1.0 | 0 | 1
|
| 587 | POLYI | 1 | 0.5 | 0 | 0
|
| 588 | POLYINOSINIC-POLYCYTIDYLIC | 2 | 1.0 | 0 | 3
|
| 589 | POLYMERIC | 1 | 0.5 | 0 | 0
|
| 590 | POLYMORPHONUCLEAR | 1 | 0.5 | 0 | 0
|
| 591 | POTENTIAL | 1 | 0.5 | 0 | 4
|
| 592 | PREFERENTIAL | 1 | 0.5 | 0 | 0
|
| 593 | PROAPOPTOTIC | 1 | 0.5 | 0 | 4
|
| 594 | PROFESSOR | 1 | 0.5 | 0 | 2
|
| 595 | PROFILING | 2 | 1.0 | 0 | 10
|
| 596 | PROMOTER | 1 | 0.5 | 0 | 1
|
| 597 | PROMOTION | 1 | 0.5 | 0 | 8
|
| 598 | PROPERTIES | 2 | 1.0 | 0 | 10
|
| 599 | PROTEASE | 1 | 0.5 | 0 | 0
|
| 600 | PROTEOLYSIS | 1 | 0.5 | 0 | 0
|
Page 3 of 4: [ 1 2 3 4 ]